Strides made in red blood cell disorders, but substantial barriers to care remain.
Hampton
Tracy
T
D000755:Anemia, Sickle Cell / Q000150:complications / Q000628:therapy; D000986:Antisickling Agents / Q000627:therapeutic use; D001565:Benzoates / Q000627:therapeutic use; D001927:Brain Diseases / Q000209:etiology; D015913:Chelation Therapy; D000077588:Deferasirox; D006402:Hematologic Diseases / Q000628:therapy*; D006405:Hematology / Q000639:trends*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007502:Iron Chelating Agents / Q000627:therapeutic use; D014230:Triazoles / Q000627:therapeutic use
D000986:Antisickling Agents; D001565:Benzoates; D007502:Iron Chelating Agents; D014230:Triazoles; D000077588:Deferasirox; D006918:Hydroxyurea